Wall Street brokerages predict that Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Rating) will report $16.67 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Tarsus Pharmaceuticals’ earnings, with estimates ranging from $15.00 million to $20.00 million. Tarsus Pharmaceuticals reported sales of $22.02 million during the same […]
RESEARCH TRIANGLE PARK - Five years after launching with a team headlined by local life sciences "rainmaker" Steve Butts and $49 million in capital, Arrivo
Five years after launching with a team headlined by local life sciences “rainmaker” Steve Butts and $49 million in capital, Morrisville-based Arrivo BioVentures is emerging from stealth mode with four drugs in its pipeline.
Ms. Crane brings over 30 years of experience in executive leadership, commercialization, and business development in the pharmaceutical and healthcare.
Tarsus Pharmaceuticals (TARS) Appoints Rosemary A Crane to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.